The use of pentoxifylline alone in HIV-infected patients
Mole, L.; Margolis, D.; Ghotbi, L.; Holodniy, M.
Journal of Acquired Immune Deficiency Syndromes 7(5): 519-521
1994
ISSN/ISBN: 0894-9255 PMID: 7908984 Document Number: 433090
Document emailed within 1 workday
Related Documents
Johnson, F.E.; Tolman, K.C.; Farr, S.A.; Davis, P.J.; Ludden, T.M.; Roy, T.K.; Raju, P.I. 1993: Serum levels of pentoxifylline and its metabolites in non-tumor-bearing mice after chronic oral pentoxifylline administration Journal of Medicine 24(2-3): 131-143Mojtahedzadeh, M.; Izadpanah, F.; Kazem Aghamir, S.M.; Atharikia, D.; Reza Nikoobahkt, M.; Abbasi, A. 2008: Effect of intravenous pentoxifylline on oxidative stress in patients undergoing nephrolithotomy Minerva Urologica e Nefrologica 60(3): 151-157
Ott, E.; Lechner, H. 1981: Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline La Ricerca in Clinica e in Laboratorio 11(Suppl 1): 253-256
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208
Atroshchenko, E.S. 1986: Use of pentoxifylline (trental) to correct microcirculatory disorders in patients with atherosclerosis of peripheral arteries Kardiologiia 26(12): 106-108
Zaccaria, A.; Antonini, M.; Marciani, A.; Taurino, M.; Speziale, F.; Spartera, C. 1981: Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities La Ricerca in Clinica e in Laboratorio 11(Suppl 1): 381-386
Rao, K.M.; Simel, D.L.; Cohen, H.J.; Crawford, J.; Currie, M.S. 1990: Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication Journal of Laboratory and Clinical Medicine 115(6): 738-744
Boldt, J.; Müller, M.; Heyn, S.; Welters, I.; Hempelmann, G. 1996: Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients Critical Care Medicine 24(6): 940-946
Heublein, B.; Franz, N.; Modersohn, D.; Linss, G.; Lange, T.; Specht, F.K.; Heublein-Balint, E.G. 1988: Effects of pentoxifylline on diastolic heart function in patients with angina pectoris and an increased left ventricular wall mass Herz 13(2): 124-135
Karim, M.R.; Ahmed, H.; Paul, R.K.; Chowdhury, M.; Alam, M.S.; Saha, A. 2016: Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients Mymensingh Medical Journal: Mmj 25(2): 198-204
Goni, B.W.; Yusuph, H.; Mustapha, S.K.; Sahabi, M.A.; Gwalabe, S.A.; Tahir, A.; Bakki, B.; Kida, I.M. 2013: Hepatic transaminase and alkaline phosphatase enzyme levels in HIV/HBV co-infected and HIV mono-infected patients in Maiduguri, Nigeria Nigerian Journal of Clinical Practice 16(4): 530-534
Chan, Y.W.; Kay, C.S. 1993: Pentoxifylline in the treatment of acute ischaemic stroke--a reappraisal in Chinese stroke patients Clinical and Experimental Neurology 30: 110-116
Miró Meda, J.M.; Mallolas Masferrer, J.; Moreno-Camacho, A.; Marco Reverter, F.; García Alcaide, F. 1997: Cryptococcus neoformans infections in patients infected and not infected with HIV Revista Clinica Espanola 197(Suppl): 49-59
Radkowski, M.; Wang, L.F.; Vargas, H.; Wilkinson, J.; Rakela, J.; Laskus, T. 2001: Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors Transplantation 72(5): 833-838
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Lee, T.S. 1992: Negative inotropism of pentoxifylline Critical Care Medicine 20(10): 1497-1498
Ruiz-Argüelles, G.J.; Lobato-Mendizábal, E.; Ruiz-Argüelles, A.; Lagunes-Yannelli, B. 1992: Pentoxifylline in the treatment of AIDS Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 44(2): 285-286
Schramm, P.; Hommel, G.; Schill, W.B. 1984: Pentoxifylline--an andrologic drug? Zeitschrift für Hautkrankheiten 59(20): 1379-1382
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
Jain, A.P.; Kazi, R.A.; Diwan, S.K.; Gupta, O.P.; Jajoo, U.N. 1992: Acute psychotic reaction to pentoxifylline Journal of the Association of Physicians of India 40(7): 479